Research records indexed for GHRP-2
This page carries 12 of the 212 records that the literature query returned for GHRP-2, selected by citation count and preferring records that name the compound in their title. It is a selection, not a complete index, and the 200 records it does not carry are not represented here. Every row resolves to a real identifier and names the study model, so no finding reads as a human claim by default. The compound page is GHRP-2.
Indexed records
| Record | Year | Study type | Model | n as stated | What it reported |
|---|---|---|---|---|---|
| Effects of GHRP-2 and Cysteamine Administration on Growth Performance, Somatotropic Axis Hormone and Muscle Protein Deposition in Yaks (Bos grunniens) with Growth Retardation pmid:26894743 | 2016 | Research Support, Non-U.S. Gov't, research-article | other | Not stated | Indexed as research support, non-u.s. gov't, research-article. study model from MeSH "Animals" with no rodent species heading. subject headings: Muscle, Skeletal; Cattle; Growth Disorders; Body Weight; Cysteamine. |
| Determination of growth hormone releasing peptides metabolites in human urine after nasal administration of GHRP-1, GHRP-2, GHRP-6, Hexarelin, and Ipamorelin pmid:25869809 | 2015 | Research Support, Non-U.S. Gov't, Validation Study | other | Not stated | Indexed as research support, non-u.s. gov't, validation study. study model from MeSH "Humans" with no interventional publication type. subject headings: Oligopeptides; Urinalysis; Chromatography, Liquid; Administration, Intranasal; Substance Abuse Detection. |
| Detection of GHRP-2 and GHRP-6 in urine samples from athletes pmid:25809000 | 2015 | Journal Article | other | Not stated | Indexed as journal article. study model from MeSH "Humans" with no interventional publication type. subject headings: Oligopeptides; Deamino Arginine Vasopressin; Athletes. |
| Identification of the growth-hormone-releasing peptide-2 (GHRP-2) in a nutritional supplement pmid:20878896 | 2010 | Research Support, Non-U.S. Gov't | other | Not stated | Indexed as research support, non-u.s. gov't. study model from assigned MeSH headings do not state a study model. subject headings: Oligopeptides; Tablets; Calibration; Chromatography, Liquid; Spectrometry, Mass, Electrospray Ionization. |
| Determination of growth hormone secretagogue pralmorelin (GHRP-2) and its metabolite in human urine by liquid chromatography/electrospray ionization tandem mass spectrometry pmid:20552695 | 2010 | Research Support, Non-U.S. Gov't, Evaluation Study | other | Not stated | Indexed as research support, non-u.s. gov't, evaluation study. study model from MeSH "Humans" with no interventional publication type. subject headings: Oligopeptides; Chromatography, Liquid; Chromatography, High Pressure Liquid; Spectrometry, Mass, Electrospray Ionization. |
| Influence of intravenous administration of growth hormone releasing peptide-2 (GHRP-2) on detection of growth hormone doping: growth hormone isoform profiles in Japanese male subjects pmid:21249726 | 2010 | Research Support, Non-U.S. Gov't | other | Not stated | Indexed as research support, non-u.s. gov't. study model from MeSH "Humans" with no interventional publication type. subject headings: Human Growth Hormone; Insulin-Like Growth Factor I; Oligopeptides; Peptide Fragments; Protein Isoforms. |
| Ghrelin receptor agonist, GHRP-2, attenuates burn injury-induced MuRF-1 and MAFbx expression and muscle proteolysis in rats pmid:19577604 | 2009 | Research Support, Non-U.S. Gov't | rodent | Not stated | Indexed as research support, non-u.s. gov't. study model from MeSH "Mice". subject headings: Muscle, Skeletal; Rats, Sprague-Dawley; Muscular Atrophy; Burns; Ubiquitin-Protein Ligases. |
| GHRP-2, a GHS-R agonist, directly acts on myocytes to attenuate the dexamethasone-induced expressions of muscle-specific ubiquitin ligases, Atrogin-1 and MuRF1 pmid:18191156 | 2008 | Research Support, Non-U.S. Gov't | rodent | Not stated | Indexed as research support, non-u.s. gov't. study model from MeSH "Mice". subject headings: Cell Line; Muscle Cells; Rats, Sprague-Dawley; Dexamethasone; Ubiquitin-Protein Ligases. |
| Anti-inflammatory effect of the ghrelin agonist growth hormone-releasing peptide-2 (GHRP-2) in arthritic rats pmid:15507538 | 2005 | Research Support, Non-U.S. Gov't | rodent | Not stated | Indexed as research support, non-u.s. gov't. study model from MeSH "Rats". subject headings: Foot; Macrophages, Peritoneal; Blood; Rats, Wistar; Arthritis, Experimental. |
| Ghrelin receptor agonist GHRP-2 prevents arthritis-induced increase in E3 ubiquitin-ligating enzymes MuRF1 and MAFbx gene expression in skeletal muscle pmid:16030067 | 2005 | Research Support, Non-U.S. Gov't | rodent | Not stated | Indexed as research support, non-u.s. gov't. study model from MeSH "Rats". subject headings: Muscle, Skeletal; Liver; Rats, Wistar; Arthritis, Experimental; Ubiquitin-Protein Ligases. |
| Growth hormone releasing peptide-2 (GHRP-2), like ghrelin, increases food intake in healthy men pmid:15699539 | 2005 | Research Support, U.S. Gov't, P.H.S., research-article | other | Not stated | Indexed as research support, u.s. gov't, p.h.s., research-article. study model from MeSH "Humans" with no interventional publication type. subject headings: Peptide Hormones; Human Growth Hormone; Oligopeptides; Placebos; Infusions, Intravenous. |
| ACTH releasing activity of KP-102 (GHRP-2) in rats is mediated mainly by release of CRF pmid:15645295 | 2005 | Journal Article | rodent | Not stated | Indexed as journal article. study model from MeSH "Rats". subject headings: Pituitary Gland; Rats, Sprague-Dawley; Corticotropin-Releasing Hormone; Oligopeptides; Radioimmunoassay. |
Where this page sits
Compound page: GHRP-2. Class: Growth hormone secretagogues.
Retrieved 2026-10-12.
Sources
- PubChem Compound Summary for CID 6918245, Pralmorelin. PubChem, National Library of Medicine (2026). pubchem:6918245
- Drugs@FDA application register query for this compound, no application records returned. U.S. Food and Drug Administration, openFDA drugsfda endpoint (2026). fda:ghrp-2
- The effect of GH-releasing peptide-2 (GHRP-2 or KP 102) on GH secretion from primary cultured ovine pituitary cells can be abolished by a specific GH-releasing factor (GRF) receptor antagonist. The Journal of endocrinology (1994). pmid:8169551
- The effects of GH-releasing peptide-6 (GHRP-6) and GHRP-2 on intracellular adenosine 3',5'-monophosphate (cAMP) levels and GH secretion in ovine and rat somatotrophs. The Journal of endocrinology (1996). pmid:8699133
- Effects of GHRP-2 and hexarelin, two synthetic GH-releasing peptides, on GH, prolactin, ACTH and cortisol levels in man. Comparison with the effects of GHRH, TRH and hCRH. Peptides (1997). pmid:9285939
- The combined administration of GH-releasing peptide-2 (GHRP-2), TRH and GnRH to men with prolonged critical illness evokes superior endocrine and metabolic effects compared to treatment with GHRP-2 alone. Clinical endocrinology (2002). pmid:12030918
- Growth hormone releasing peptide-2 (GHRP-2), like ghrelin, increases food intake in healthy men. The Journal of clinical endocrinology and metabolism (2005). pmid:15699539
- Anti-inflammatory effect of the ghrelin agonist growth hormone-releasing peptide-2 (GHRP-2) in arthritic rats. American journal of physiology. Endocrinology and metabolism (2005). pmid:15507538
- Ghrelin receptor agonist GHRP-2 prevents arthritis-induced increase in E3 ubiquitin-ligating enzymes MuRF1 and MAFbx gene expression in skeletal muscle. American journal of physiology. Endocrinology and metabolism (2005). pmid:16030067
- Identification of the growth-hormone-releasing peptide-2 (GHRP-2) in a nutritional supplement. Drug testing and analysis (2010). pmid:20878896
- Determination of growth hormone secretagogue pralmorelin (GHRP-2) and its metabolite in human urine by liquid chromatography/electrospray ionization tandem mass spectrometry. Rapid communications in mass spectrometry : RCM (2010). pmid:20552695
On each stated value was matched to the record cited for it. That is record matching, not an appraisal of the research. Compiled and checked by: Peptide Monographs editorial desk. No qualified clinical reviewer.